Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program

Basit Öğe Kaydı
dc.contributor.authorIdilman, R.
dc.contributor.authorDemir, M.
dc.contributor.authorAladag, M.
dc.contributor.authorKaymakoglu, S.
dc.contributor.authorErol, C.
dc.contributor.authorCavus, B.
dc.contributor.authorIliaz, R.
dc.contributor.authorAkarca, U. S.
dc.contributor.authorKoklu, S.
dc.contributor.authorCakaloglu, Y.
dc.contributor.authorSahin, M.
dc.contributor.authorKoksal, I.
dc.contributor.authorOzgenel, M.
dc.contributor.authorToka, B.
dc.contributor.authorKarasu, Z.
dc.contributor.authorErsoz, G.
dc.contributor.authorKiyici, M.
dc.contributor.authorAkdogan, M.
dc.contributor.authorTurkey, E. A. P.
dc.date.accessioned2019-10-27T10:06:33Z
dc.date.available2019-10-27T10:06:33Z
dc.date.issued2018
dc.departmentEge Üniversitesien_US
dc.descriptionInternational Liver Congress (ILC) -- APR 11-15, 2018 -- Paris, FRANCEen_US
dc.description.sponsorshipEuropean Assoc Study Liveren_US
dc.identifier.endpageS301en_US
dc.identifier.issn0168-8278
dc.identifier.issn1600-0641
dc.identifier.startpageS301en_US
dc.identifier.urihttps://hdl.handle.net/11454/30467
dc.identifier.volume68en_US
dc.identifier.wosWOS:000461068601213en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevier Science Bven_US
dc.relation.ispartofJournal of Hepatologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleRecurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access programen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu